Submit Deal

Submit Deal

Cover Image Eduardo Bravo

Eduardo Bravo

CEO at TIGENIX NV

Manager

Deal Bio

Total Deals1

Valued Deals1

Total Value£ 445 M

Avg. Deal Size£ 445 M

Market Context

Sort

05 Jan 2018|Netherlands|Biotechnology

Target: TIGENIX NV

Bidder: TAKEDA PHARMACEUTICAL COMPANY LIMITED

7 Service Providers

4 Target | 3 Bidder

12 Dealmakers

9 Target | 3 Bidder

£ 445 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

Privacy Policy Terms of Service Contact Us Cookie Preferences

All rights reserved. Copyright © 2025 Datasite